Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-31

FDA Approved: OXYCODONE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Lupin Pharmaceuticals' generic oxycodone hydrochloride product (ANDA 204603).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxycodone hydrochloride (Oxycodone hydrochloride)

Snippet

SUPPL AP for OXYCODONE HYDROCHLORIDE (OXYCODONE HYDROCHLORIDE)